Los Angeles-based biomedical firm ImaginAb has announced June 3 that the company is working with researchers at the University of California and has settled on a technology licensing agreement for the developmentof investigational immune cell PET agents.

ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand the clinical development of this promising imaging agent in the US and internationally.

Remediation of Parkinson’s via stem cell transplantation has been verified and dopamine transporter (DAT) expression was found to be normal not just in short-term studies, but for 4-14 years after transplantation of dopamine neurons, according to a study published June 5 in Cell Reports.

The new cancer center paradigm provides genetic tests not just for experimental research, but as a clinical standard. In this glimpse by Bloomberg, Memorial Sloan Kettering Cancer Center shows off a new laboratory opened just weeks ago where patients' biopsies will be tested for 341 mutations associated with disease.

Bethesda, MD (June 3, 2014) The American Society of Nuclear Cardiology (ASNC) will be offering a Nuclear Cardiology Board Exam Preparation Course from July 11-13 at the Intercontinental Hotel Chicago O'hare in Rosemont, Ill.

Using high-powered electron microscopy, scientists at the Scripps Research Institute in La Jolla, Calif., have uncovered one of the most important cellular mechanisms of gene expression, the Mediator, according to a study published today in the journal Cell. The researchers’ new map of cellular machinery is key to a deeper understanding of cellular processes, including the production of proteins.

An outline of the science resulting from the $4.5 billion funding earmarked by a recent federal report for the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was released today by the National Institutes of Health (NIH).

Saturday marks the first day of the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting being held June 7-11 at the St. Louis Convention Center. This year is the banner 60th anniversary of the SNMMI Annual Meeting, jam-packed with plenary and scientific sessions as well as an exhibition of technologies and services catered exclusively to professionals in the field of molecular imaging.